• CH 223191: Mapping AhR-Driven Ovarian Toxicity

  2026-08-09

  CH 223191 is a potent aryl hydrocarbon receptor antagonist for resolving how environmental ligands alter endocrine tissues. This guide translates ovarian follicle evidence into a pathway-centered assay strategy that distinguishes AhR engagement from nonspecific toxicity.

• Self-Amplifying RNA Vaccines for Seasonal Influenza

  2026-08-08

  This 2026 study shows that self-amplifying RNA can overcome the weak influenza B immunogenicity observed with conventional nucleoside-modified mRNA in mice. At a low dose, trivalent saRNA generated durable antibody responses and complete protection against influenza B challenge, highlighting platform- and subtype-specific determinants of RNA vaccine performance.

• Tivozanib (AV-951): Measure More Than Viability

  2026-08-07

  Tivozanib (AV-951) is a selective VEGFR inhibitor whose biology can be obscured by conventional viability assays. This guide connects VEGFR pathway pharmacology with a more rigorous framework for separating growth inhibition from true cell killing in oncology research.

• Radioiodinated Balsalazide: Advancing UC Imaging in Mice

  2026-08-07

  Sanad et al. present a robust protocol for radioiodinating balsalazide, yielding a highly selective, stable radiotracer for imaging ulcerative colitis (UC) in mice. Their work enables precise, extended biodistribution studies in preclinical UC models, addressing key shortcomings of prior radiotracers.

• H 89 2HCl: Precision PKA Inhibition in cAMP Signaling Assays

  2026-08-06

  H 89 2HCl empowers researchers to dissect cAMP/PKA signaling with high selectivity and reproducibility, as evidenced in studies on neuronal calcium modulation and protein phosphorylation. This article demystifies experimental workflows, protocol tuning, and troubleshooting strategies for leveraging H 89 2HCl in advanced cellular models.

• NMDA (N-Methyl-D-aspartic acid) in Advanced Excitotoxicity M

  2026-08-06

  Leverage NMDA (N-Methyl-D-aspartic acid) for highly reproducible modeling of excitotoxicity, ferroptosis, and neurodegeneration. This article delivers optimized protocols, troubleshooting essentials, and practical insights from cutting-edge glaucoma research to power your next neuroscience experiment.

• Pregnenolone Carbonitrile: Advanced Workflows in Hepatic and

  2026-08-05

  Pregnenolone Carbonitrile stands out as a versatile tool for dissecting PXR-mediated hepatic detoxification and unraveling glucocorticoid receptor-dependent neuroprotection. This article translates cutting-edge reference findings and best practices into actionable protocols, troubleshooting tips, and workflow innovations for biomedicine.

• GSK621: Advanced AMPK Agonist for AML and Metabolic Research

  2026-08-05

  GSK621, a potent AMPK agonist from APExBIO, delivers unmatched control over metabolic and immunometabolic pathways, setting a benchmark in apoptosis and autophagy studies—especially in acute myeloid leukemia research. Explore optimized protocols, troubleshooting strategies, and insights from the latest immunometabolic reference study to accelerate your research outcomes.

• Reactive Oxygen Species Assay Kit (DHE): Mechanism & Benchma

  2026-08-04

  The Reactive Oxygen Species Assay Kit (DHE) enables precise detection of intracellular superoxide in living cells using a dihydroethidium (DHE) probe. This kit supports robust oxidative stress assays and advanced apoptosis research workflows by providing quantitative, reproducible results. APExBIO’s K2066 kit is benchmarked by peer-reviewed evidence and optimally designed for redox biology applications.

• Silymarin: Applied Protocols for Oxidative Stress and Cancer

  2026-08-04

  Silymarin, a milk thistle extract, is redefining experimental workflows in oxidative stress and oncology research with robust, reproducible outcomes. This article translates recent structural and mechanistic insights into practical, stepwise protocols—empowering researchers to maximize assay reliability and troubleshoot common solubility and stability challenges.

• Lumiracoxib in Microvascular Regeneration: Beyond COX-2 Inhi

  2026-08-03

  Explore how Lumiracoxib, a potent selective COX-2 inhibitor, uniquely informs microvascular regeneration and inflammation research. This article delivers a deeper mechanistic analysis and practical guidance for leveraging Lumiracoxib in advanced tissue injury and angiogenesis models.

• Chemerin in cNTS Drives Sympathetic Activity via Superoxide

  2026-08-03

  This study uncovers a novel mechanism by which chemerin in the caudal nucleus tractus solitarius (cNTS) enhances sympathetic outflow and elevates blood pressure through CMKLR1-mediated superoxide generation. The findings clarify that these cardiovascular effects are independent of AMPA/kainate glutamatergic signaling, refining understanding of neurogenic blood pressure regulation.

• Oridonin Suppresses Esophageal Cancer via TLR4/NF-κB/NLRP3 A

  2026-08-02

  This study demonstrates that oridonin inhibits esophageal cancer progression in mice by targeting the TLR4/NF-κB/NLRP3 inflammasome pathway. The results highlight the mechanistic relevance of chronic inflammation in tumor development and provide new insights for research into anti-inflammatory interventions in cancer.

• Capecitabine in Assembloid Oncology: Protocols & Troubleshoo

  2026-08-01

  Capecitabine, a tumor-targeted fluoropyrimidine prodrug, empowers preclinical oncology by enabling physiologically relevant modeling of chemotherapy selectivity and apoptosis within advanced assembloid systems. Discover stepwise protocols, optimization strategies, and translation of seminal assembloid research for effective application of Capecitabine in the study of tumor–stroma interactions and drug resistance.

• HyperScribe All in One mRNA Synthesis Kit Plus 1: Advanced A

  2026-07-31

  Unlock seamless, immune-evasive mRNA synthesis with the HyperScribe All in One mRNA Synthesis Kit Plus 1. This kit streamlines ARCA capping, 5mCTP/ψUTP modification, and poly(A) tailing for high-yield, translational mRNA—empowering RNA vaccine development and advanced functional assays.

14845 records 1/990 page Next 12345 下5页 Last page